| |
|
|
|
Gritstone Oncology Inc.  
|
|
2.65 0 (0%) |
09-30 16:00 |
|
Open: |
2.66 |
Pre close: |
2.65 |
Target:
|
3.65
|
|
High: |
2.74 |
Low: |
2.6354 |
Resistance:
|
3.12
3.43
|
|
Volume: |
226,428 |
Market Cap: |
100M |
Support:
|
2.63
2.19
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.72
 |
MACD |
MACD(12,26):
|
-0.20 |
|
MA(20): |
3.02 |
Signal(12,26,9): |
-0.18 |
|
MA(100): |
4.79 |
Stochastic Oscillator |
%K(14,3):
|
4.41 |
|
MA(250): |
6.78 |
%D(3): |
4.84 |
|
Average Volume(K) |
3-Month: |
80914
|
52-Week |
High:
|
12.96 |
|
10-Days: |
30971 |
Low: |
2.63 |
|
RSI |
RSI(14):
|
32.48  |
Change(%): |
-69.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.946 |
Return on Equity (ttm) |
-77.0 |
Shares Out. (M) |
37.75 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-36.6 |
Shares Float (M) |
23.04 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.07 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-57.6 |
% Held by Institutions |
79.17 |
|
Forward EPS |
-2.810 |
Gross Profit (p.s.) |
-2.080 |
Shares Short (K) |
2080 |
|
Book Value (p.s.) |
2.550 |
EBITDA (p.s.) |
-2.745 |
P/E |
-0.91 |
|
Sales Per Share |
0.096 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.05 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-91.18 |
P/S |
27.84 |
|
Operating Margin |
-3027.23 |
Levered Free Cash Flow
(M) |
-69.34 |
P/CF |
-1.11 |
|
|
|
|
|
|
